Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies
Breast cancer is a global health challenge with staggering statistics underscoring its
pervasive impact. The burden of this disease is measured in terms of its prevalence and the …
pervasive impact. The burden of this disease is measured in terms of its prevalence and the …
Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based …
Addressing breast cancer is an ongoing global health concern, demanding constant
progress in treatment approaches due to its high incidence and mortality rates. In recent …
progress in treatment approaches due to its high incidence and mortality rates. In recent …
[图书][B] CPP, cell-penetrating peptides
Ü Langel - 2019 - Springer
The genesis of cell-penetrating peptide research (CPP; also known as prote/peptide
transduction domains, PTD, or Trojan peptides) was born from the publication of two parallel …
transduction domains, PTD, or Trojan peptides) was born from the publication of two parallel …
Self-assembly of hydrazide-linked porous organic polymers rich in titanium for efficient enrichment of glycopeptides and phosphopeptides from human serum
D Wang, Q Feng, Y Luo, W Wang, Y Yan, CF Ding - Analyst, 2023 - pubs.rsc.org
In this work, titanium-rich hydrazide-linked porous organic polymers (hydrazide-POPs-Ti4+)
were synthesized using hydrazine, 2, 3-dihydroxyterephthalaldehyde (DHTA) and trimethyl …
were synthesized using hydrazine, 2, 3-dihydroxyterephthalaldehyde (DHTA) and trimethyl …
GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights
D Zhang, M Wang, X Huang, L Wang, Y Liu… - Frontiers in …, 2023 - frontiersin.org
Background Recently, a novel programmed cell death mechanism, Cuproptosis, has been
discovered and found to play an important role in the development and progression of …
discovered and found to play an important role in the development and progression of …
Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review
I Saranya, VS Dharshini, RL Akshaya… - International Journal of …, 2024 - Elsevier
Breast cancer (BC) is a global health concern, and development of diagnostic tools and
targeted treatments for BC remains challenging. Therapeutic approaches for BC often …
targeted treatments for BC remains challenging. Therapeutic approaches for BC often …
Bringing bioactive peptides into drug discovery: Challenges and opportunities for medicinal plants
The pervasiveness of lifestyle diseases is gradually increasing at an alarming rate
worldwide. Physicians are prescribing many drug interventions to patients; however, the …
worldwide. Physicians are prescribing many drug interventions to patients; however, the …
[HTML][HTML] Short Peptides as Powerful Arsenal for Smart Fighting Cancer
J Bojarska, WM Wolf - Cancers, 2024 - mdpi.com
Simple Summary This mini-review summarizes the up-to-date progress in developing
anticancer therapies based on cutting-edge strategies employing short peptides. This work …
anticancer therapies based on cutting-edge strategies employing short peptides. This work …
Dermaseptin B2 bioactive gene's potential for anticancer and anti-proliferative effect is linked to the regulation of the BAX/BBC3/AKT pathway
FK Nasirabadi, A Doosti - Medical Oncology, 2024 - Springer
Abstract Dermaseptin B2 (DrsB2) is an antimicrobial peptide with anticancer and angiostatic
properties. We aimed to assess the in vitro inhibitory effect of pDNA/DrsB2 on the growth of …
properties. We aimed to assess the in vitro inhibitory effect of pDNA/DrsB2 on the growth of …
Tackling suppressive cancer microenvironment by NARF-derived immune modulatory vaccine and its validation using simulation strategies
P Paranthaman, S Veerappapillai - Frontiers in Physics, 2024 - frontiersin.org
Introduction: Targeting tumor microenvironment is beneficial and present an ideal setting for
the development of futuristic immunotherapy. Here, we make use of Nuclear prelamin A …
the development of futuristic immunotherapy. Here, we make use of Nuclear prelamin A …